Combined Microneedling Therapy: The Largest Meta-Analysis Yet (2024, 696 Patients)

Key Takeaways

  • Combined microneedling is better than any single treatment — pooled data from 13 randomised trials (696 patients) shows significantly greater hair density and diameter improvements.
  • Hair density increased by 13.4–18.1 hairs/cm² more than monotherapy groups (p < 0.00001) — a clinically meaningful improvement visible to the naked eye.
  • Both hair count AND hair thickness improved — unlike some previous analyses, this review found benefits for both measures (hair diameter MD = 2.50, p = 0.001).
  • Safety profile is comparable to single treatments — no increase in adverse effects when adding microneedling to your routine (p = 0.22).
  • Doctor satisfaction was significantly higher with combined therapy (RR = 2.03, p < 0.00001), though patient satisfaction was similar between groups.

Research Evidence Summary

Condition Androgenetic alopecia (pattern hair loss)
Treatment Microneedling combined with topical therapy (e.g., minoxidil, PRP, growth factors)
Evidence Level Systematic review and meta-analysis of 13 randomised controlled trials
Sample Size 696 patients across 13 RCTs
Primary Outcome Statistically significant increase in hair density (MD = 13.36–18.11, p < 0.00001) and hair diameter (MD = 2.50, p = 0.001)
Safety Profile No significant increase in adverse events compared to monotherapy (RR = 0.83, p = 0.22)

About This Study

Authors Danning Pei, Linxi Zeng, Xin Huang, Bin Wang, Lu Liu, Guoqiang Zhang
Institution Department of Dermatology, The First Hospital of Hebei Medical University, China
Journal Journal of Cosmetic Dermatology
Year 2024 (Volume 23, Issue 5, Pages 1560–1572)
Type Systematic Review & Meta-analysis (13 RCTs, 696 patients)
PMID 38239003
Full Paper View on PubMed | DOI: 10.1111/jocd.16186
Note: This is a plain-language summary of the published research paper. The original study was conducted independently and is not affiliated with Hairgenetix. We present this summary to make scientific research more accessible to people experiencing hair loss.
Reviewed by: Esther Bodde — Cosmetic & Medical Doctor (MD)

Why This Research Matters

This is the largest meta-analysis on combined microneedling therapy for androgenetic alopecia to date — 13 randomised controlled trials involving 696 patients. That's nearly three times the number of patients included in the earlier Gupta 2022 meta-analysis.

What makes this study particularly significant is that it found improvements in both hair density AND hair diameter — a finding that differs from some earlier analyses that only found density improvements. This suggests that with sufficient data, microneedling may benefit hair quality as well as quantity.

For anyone considering microneedling as part of their hair loss treatment, this study provides the strongest evidence yet that combining microneedling with other therapies produces better outcomes than using any single treatment alone.

What The Researchers Did

Pei and colleagues systematically searched medical databases (PubMed, Embase, Cochrane Library, Web of Science) for all randomised controlled trials comparing combined microneedling therapy (microneedling + topical treatment) versus single-treatment approaches for androgenetic alopecia. They analysed outcomes including:

  • Hair density (hairs per cm²)
  • Hair diameter (thickness of individual hair strands)
  • Doctor satisfaction with treatment results
  • Patient satisfaction with treatment results
  • Adverse event rates

The analysis followed PRISMA guidelines and used the Cochrane risk-of-bias tool to assess study quality.

What Is a Meta-Analysis?

A meta-analysis is a statistical method that combines results from multiple independent clinical trials to produce a single, more powerful conclusion. It is considered the highest level of clinical evidence in the evidence hierarchy — above individual randomised trials, cohort studies, and expert opinion.

Why does this matter? Individual studies may have small sample sizes or varying conditions that limit their conclusions. By pooling data from 13 separate trials involving 696 patients, this meta-analysis can detect treatment effects that might be too small to reach statistical significance in any single study. It also reduces the risk that unusual results from one trial dominate the conclusions.

The researchers used two key quality controls: PRISMA guidelines (a standardised checklist ensuring the review is comprehensive and transparent) and the Cochrane risk-of-bias tool (which evaluates whether each included trial was conducted fairly, with proper randomisation and blinding).

What They Found

Hair density — significant improvement (p < 0.00001): The combined microneedling group showed a mean difference of 13.36–18.11 additional hairs per cm² compared to any single treatment approach. This was the most robust finding in the analysis, with narrow confidence intervals indicating high reliability.
Hair diameter — also improved (p = 0.001): Unlike previous smaller analyses, this larger dataset revealed that combined microneedling also significantly improved hair shaft diameter (MD = 2.50, 95% CI [0.99, 4.02]). This means it helps grow thicker hairs, not just more of them.
Safety — no additional risk (p = 0.22): There was no statistical difference in adverse event rates between combined microneedling therapy and monotherapy (RR = 0.83). Adding microneedling to your routine does not increase the risk of side effects.
Professional endorsement (p < 0.00001): Doctor satisfaction was more than twice as high with combined therapy (RR = 2.03), reflecting visible improvements that clinicians could objectively measure through trichoscopy and photography.
Bar chart showing combined microneedling therapy versus monotherapy results from Pei et al. 2024 meta-analysis: hair density improvement of +18.1 hairs per cm squared (p less than 0.00001), hair diameter improvement of +2.50 micrometers (p equals 0.001), and doctor satisfaction 2 times higher (RR 2.03, p less than 0.00001). Data from 13 randomised controlled trials involving 696 patients.
Data from Pei et al. 2024 meta-analysis of 13 RCTs (696 patients). Combined microneedling therapy significantly outperformed monotherapy across all three measures.

How Microneedling Stimulates Hair Growth

Microneedling works through several biological mechanisms that explain why it enhances the effectiveness of hair loss treatments:

  • Wound-healing response: Microneedling creates controlled micro-injuries in the scalp, triggering the release of growth factors (including platelet-derived growth factor and epidermal growth factor) that stimulate hair follicle regeneration.
  • Wnt/β-catenin pathway activation: The wound-healing cascade activates the Wnt signalling pathway, which plays a central role in hair follicle development and the transition from resting (telogen) to growth (anagen) phase.
  • VEGF upregulation: Microneedling increases vascular endothelial growth factor expression, improving blood supply to hair follicles — better blood flow means more nutrients and oxygen reaching the dermal papilla cells.
  • Stem cell activation: The micro-injuries may activate follicular stem cells in the bulge region, prompting them to contribute to new hair growth cycles.
  • Enhanced drug penetration: Microneedling creates microchannels in the stratum corneum, allowing topical treatments like minoxidil or copper peptide serums to penetrate deeper into the scalp and reach hair follicles more effectively. Studies suggest penetration improves by up to 80-fold through these channels.

This dual mechanism — direct follicle stimulation plus enhanced treatment delivery — is why combination therapy consistently outperforms either microneedling or topical treatment alone.

Clinical Interpretation

Several important conclusions emerge from this meta-analysis:

  • Microneedling functions as both a therapy and a delivery system. The combined benefits of follicle stimulation and enhanced drug penetration create a synergistic effect that exceeds the sum of individual treatments.
  • Hair diameter improvement is a particularly meaningful finding. In androgenetic alopecia, follicle miniaturisation (progressive shrinking of hair shafts) is the core pathological process. Evidence that microneedling can reverse this — producing thicker hairs — suggests it may address the underlying disease mechanism, not just the symptoms.
  • The safety data is reassuring for clinical adoption. With no increase in adverse events across 696 patients, microneedling can be recommended as a low-risk addition to existing treatment plans.
  • The gap between doctor and patient satisfaction deserves attention. While objective measures showed clear improvement, patients may need longer treatment periods or better expectation-setting to appreciate the results.

How This Compares With Other Research

The Pei 2024 meta-analysis aligns with and extends findings from several earlier studies available in our research library:

  • Gupta et al. 2022 meta-analysis — An earlier meta-analysis that also found microneedling improves hair density, but with fewer trials included. The Pei study nearly triples the patient count, providing more statistical power.
  • Abdi et al. 2023 meta-analysis — Focused specifically on microneedling combined with minoxidil and confirmed that the combination produces stronger hair-growth outcomes than minoxidil alone.
  • Xu et al. 2024 meta-analysis — Another 2024 meta-analysis that found microneedling plus topical treatment produces approximately 16 extra hairs per cm² — consistent with the Pei findings.
  • Dhurat et al. 2013 landmark study — The original randomised trial that first demonstrated microneedling's potential for hair loss, which all subsequent meta-analyses build upon.
  • Faghihi et al. 2021 depth comparison — Explored optimal needle depth, finding that shallower needles (0.6 mm) may be as effective as deeper ones (1.2 mm) — relevant to protocol decisions.

Taken together, the growing body of evidence from multiple independent research groups strongly supports microneedling as an effective complementary therapy for androgenetic alopecia.

Typical Microneedling Protocols Used in the Studies

The 13 clinical trials in this meta-analysis used varying protocols. Below are the typical parameters reported across the studies:

Parameter Typical Range
Needle depth 0.5 mm – 1.5 mm (most commonly 1.0–1.5 mm)
Treatment frequency Every 1–4 weeks (most commonly every 2 weeks)
Treatment duration 12–24 weeks
Device type Derma roller or automated microneedling pen
Combined therapies Minoxidil (most common), PRP, growth factor serums
Application timing Topical applied immediately after or within 24 hours of microneedling

Note: These are the parameters used in clinical research. Individual treatment plans should be discussed with a healthcare professional.

Limitations of the Research

Although the results are robust, several limitations should be considered:

  • Heterogeneity across studies: The 13 trials used different microneedling devices, needle depths, treatment frequencies, and combination therapies, making direct comparisons challenging.
  • Varying follow-up periods: Studies ranged from 12 to 24 weeks, and long-term outcomes beyond 6 months remain unclear.
  • Limited diversity in study populations: Most trials were conducted in Asia, and results may vary across different ethnic groups and hair types.
  • No standardised outcome measures: Hair density was measured differently across studies (trichoscopy, photography, manual counting), which could introduce measurement variability.
  • Publication bias risk: Studies showing positive results are more likely to be published, which could slightly overstate the true effect size.

Despite these limitations, the consistency of positive findings across 13 independent trials from different research groups provides strong collective evidence.

What This Means For Your Hair

  • The evidence for microneedling keeps getting stronger. With 696 patients across 13 high-quality trials, this is the most robust data available that microneedling works for hair loss.
  • Combined therapy is the way to go. Microneedling alone has benefits, but pairing it with topical treatments like copper peptide serums, minoxidil, or growth factors produces significantly better outcomes.
  • It may help with hair quality too. The hair diameter findings suggest microneedling could help reverse the thinning (miniaturisation) that characterises androgenetic alopecia — not just grow more hairs, but thicker ones.
  • It's safe to add to your routine. No increase in side effects means microneedling is a low-risk addition to existing treatment plans.

Key Terms Explained

Meta-analysis
A statistical method that combines results from multiple independent studies to produce a single, more powerful estimate of a treatment's effect. Considered the highest level of clinical evidence because it pools data from many trials rather than relying on a single study.
Hair Density vs Hair Diameter
Hair density measures how many hairs grow per cm² of scalp. Hair diameter measures the thickness of individual hair strands. Both contribute to the appearance of "full" hair — you need enough hairs AND those hairs need to be thick enough to provide coverage.
Miniaturisation
The process by which hair follicles progressively shrink under the influence of DHT (dihydrotestosterone), producing thinner, shorter, lighter hairs with each growth cycle. Eventually, the hairs become so thin they're invisible. Reversing miniaturisation means making follicles produce thicker hairs again.
Randomised Controlled Trial (RCT)
An experiment where participants are randomly assigned to receive either the treatment being tested or a comparison treatment. Randomisation reduces bias and is considered the gold standard for evaluating treatment effectiveness.
Wnt/β-catenin Pathway
A cellular signalling pathway that plays a critical role in hair follicle development and cycling. When activated, it promotes the transition from the resting phase (telogen) to the growth phase (anagen), essentially "waking up" dormant follicles.

Frequently Asked Questions

Does microneedling help with hair loss?

Yes. This meta-analysis of 13 randomised clinical trials (696 patients) found that microneedling combined with topical treatments significantly improved both hair density and hair diameter compared to using topical treatments alone. The improvement in hair density was statistically significant at p < 0.00001.

Is microneedling effective for androgenetic alopecia?

Yes. Multiple meta-analyses, including this 2024 study by Pei et al., confirm that microneedling combination therapy improves hair growth outcomes in androgenetic alopecia. The evidence is strongest for combination therapy (microneedling plus a topical treatment) rather than microneedling alone.

Why does microneedling improve hair-loss treatment results?

Microneedling works through two complementary mechanisms: (1) it triggers wound-healing signals that stimulate hair follicle regeneration through the Wnt/β-catenin pathway and VEGF upregulation, and (2) it creates microchannels in the scalp that allow topical treatments to penetrate up to 80 times more effectively, reaching the hair follicles directly.

How often should microneedling be performed for hair loss?

Clinical trials in this meta-analysis typically used treatment frequencies of every 1–4 weeks, with every 2 weeks being the most common schedule. Treatment durations ranged from 12 to 24 weeks. The optimal frequency may depend on needle depth — shallower needles (0.5 mm) may allow more frequent sessions than deeper needles (1.5 mm).

What needle depth is best for hair loss microneedling?

Studies in this meta-analysis used needle depths from 0.5 mm to 1.5 mm. Research by Faghihi et al. (2021) suggests that shallower depths (0.6 mm) may be as effective as deeper ones (1.2 mm), with less discomfort. The most important factor appears to be consistency of treatment rather than needle depth alone.

Why did this study find hair diameter improvements when others didn't?

Statistical power. This study included nearly 700 patients from 13 trials, compared to smaller earlier analyses. With more data, smaller but real effects become statistically detectable. The hair diameter improvement was likely present in earlier studies but couldn't reach statistical significance with fewer patients.

Why was doctor satisfaction higher but not patient satisfaction?

Doctors assess improvement using objective measures (trichoscopy, standardised photography). Patients assess based on how they feel about their appearance, which is influenced by expectations and self-perception. A 10–15% improvement in density might be clearly visible to a dermatologist with a microscope but not as noticeable to the patient looking in the mirror.

Can microneedling be combined with copper peptide treatments?

Yes. While most studies in this meta-analysis combined microneedling with minoxidil or PRP, recent research by Kuceki et al. (2025) specifically studied copper peptide microneedling and found 26.5% hair regrowth in 5 monthly sessions. The penetration-enhancing effect of microneedling applies to any topical treatment, including copper peptide serums.

Original Study Citation

Pei, D., Zeng, L., Huang, X., Wang, B., Liu, L., & Zhang, G. (2024). Efficacy and safety of combined microneedling therapy for androgenic alopecia: A systematic review and meta-analysis of randomized clinical trials. Journal of Cosmetic Dermatology, 23(5), 1560–1572. https://doi.org/10.1111/jocd.16186 | PubMed: 38239003

How to Cite This Research Summary

Hairgenetix Research Team. "Combined Microneedling Therapy: The Largest Meta-Analysis Yet (2024, 696 Patients)." Hairgenetix Research Library, March 2026.
Available at: https://hairgenetix.com/blogs/articles/combined-microneedling-therapy-meta-analysis-pei-2024

Last updated: March 2026
Hairgenetix Research Library — Evidence-based summaries of peer-reviewed clinical research on hair restoration therapies, including microneedling, mesotherapy, copper peptide treatments, and regenerative hair science. All summaries are based on published studies from indexed medical journals and link directly to the original papers.
Back to Articles